BRCA1 MUTATION CARRIER
Clinical trials for BRCA1 MUTATION CARRIER explained in plain language.
Never miss a new study
Get alerted when new BRCA1 MUTATION CARRIER trials appear
Sign up with your email to follow new studies for BRCA1 MUTATION CARRIER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy targets Hard-to-Treat recurrent cancers
Disease control OngoingThis early-phase trial tests two different drug combinations—olaparib plus vistusertib, or olaparib plus capivasertib—in people with recurrent endometrial, triple-negative breast, ovarian, primary peritoneal, or fallopian tube cancer. The main goal is to find the safest dose and …
Matched conditions: BRCA1 MUTATION CARRIER
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a common diabetes drug stop breast cancer before it starts?
Prevention OngoingThis phase 3 trial tests whether taking metformin for 12 months can reduce abnormal cells in the breast tissue of women at high risk for breast cancer. Participants have conditions like atypical hyperplasia or a strong family history. Researchers compare metformin to a placebo to…
Matched conditions: BRCA1 MUTATION CARRIER
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Prevention
Last updated Jun 27, 2026 12:25 UTC